Japanese Tobacco Stock News

When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Oracle...

Investors were underwhelmed by the solid earnings posted by TWOSTONE&Sons Inc. ( TSE:7352 ) recently. We have done some...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights The considerable ownership by retail investors in SAKURA Internet indicates that they collectively have a...

Thinking about what to do with Metaplanet stock? You are certainly not alone. After all, when a company rockets an eye-catching 324.3% in a single year, it is easy to wonder if you have missed the boat or if there is more room for growth ahead. Metaplanet’s price swings tell an intriguing story. Over the last week, shares are up a healthy 7.5%, but take a step back and you will see some contrasting signals with a 5.6% pullback over the last month. Longer time frames show just how much this...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Solid profit numbers didn't seem to be enough to please System Integrator Corp.'s ( TSE:3826 ) shareholders. We think...

STUDIO ALICE Co.,Ltd.'s ( TSE:2305 ) recent earnings report didn't offer any surprises, with the shares unchanged over...

Arigatou Services Company, Limited ( TSE:3177 ) just reported healthy earnings but the stock price didn't move much...

Investors weren't pleased with the recent soft earnings report from Chiyoda Co., Ltd. ( TSE:8185 ). Our analysis...

Mitsubishi Estate Logistics REIT Investment (TSE:3481) made waves with its latest earnings guidance for fiscal 2026, along with a sharply reduced distribution forecast for February that is certain to catch investors’ attention. See our latest analysis for Mitsubishi Estate Logistics REIT Investment. News of sharply lower distribution guidance for early 2026 comes as Mitsubishi Estate Logistics REIT Investment has quietly regained some momentum. The stock has seen a 6.9% share price return...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights Institutions' substantial holdings in BANDAI NAMCO Holdings implies that they have significant influence...

Ono Pharmaceutical recently presented two-year efficacy and safety data from the MOTION Phase 3 study of vimseltinib in patients with tenosynovial giant cell tumor (TGCT) ineligible for surgery at the 2025 European Society for Medical Oncology Congress in Berlin. The long-term results underscore vimseltinib’s potential as a treatment option for individuals with limited alternatives, marking an important achievement in Ono's oncology pipeline. We’ll explore how these positive long-term...

On October 15, 2025, PDRadiopharma Inc., PeptiDream Inc., and Curium Group announced the initiation of a registrational Phase 2 trial in Japan for 64Cu-PSMA-I&T, an innovative PET radiopharmaceutical imaging agent targeting prostate-specific membrane antigen in prostate cancer. This development strengthens the collaborative pipeline for advanced prostate cancer diagnostics and highlights increasing industry attention toward radiopharmaceuticals with both diagnostic and therapeutic...

On October 16, 2025, Nomura Real Estate Master Fund announced lower distribution per unit for the coming periods and issued new earnings guidance, including an expected distribution of ¥3,124 per unit for both the periods ending February and August 2026, down from the previous year's payouts. This combination of reduced forecasted distributions and moderated profit expectations signals potential challenges in sustaining previous levels of investor returns. We’ll explore how the anticipated...

Takashimaya Company (TSE:8233) has drawn investor attention this week after announcing a series of significant updates. These include revised financial guidance, a new dividend outlook, and the decision to close and sell its Rakusai Store property. See our latest analysis for Takashimaya Company. This run of announcements, from the Rakusai Store closure and property sale to a new dividend forecast and refreshed sales figures, has likely contributed to Takashimaya's strong share price...

If you are considering what to do with your ZOZO shares right now, you are not alone. Investors are taking a close look at this Japanese e-commerce leader after a stretch of uneven performance. There is no denying the excitement around ZOZO’s longer-term record, with the stock up 70.1% over the last five years and climbing 40.4% over three. However, more recent returns have been less inspiring. Over the past year, ZOZO’s share price has fallen 16.2%, a trend that continued into this year with...

Canon Electronics (TSE:7739) reported a net profit margin of 6.6%, pulling back from 7.7% in the previous period, while earnings expanded at an average annual rate of 10.9% over the last five years. Despite a recent decline in earnings growth, the company’s high quality earnings, price-to-earnings ratio of 16.3x (below the peer average but above the industry), and share price of ¥2,753, which trades below its estimated fair value of ¥3,606.36, are drawing investors’ attention. As investors...

Bull-Dog Sauce (TSE:2804) posted an impressive 809.1% jump in yearly earnings, propelled by a one-off gain of ¥2.8 billion, which sent net profit margins soaring to 17.1% from last year’s 1.9%. Over the past five years, earnings have grown at an average pace of 14.1% per year, highlighting a trend of sustained profitability. While these headline results appear strong, it is clear that the most recent boost in net income reflects exceptional factors rather than ongoing business...

Shin-Etsu Chemical (TSE:4063) posted a net profit margin of 19.3%, down from last year’s 20.6%, with earnings expanding at an average rate of 8.9% per year over the past five years despite a recent dip in yearly earnings. Looking ahead, analysts expect annual earnings growth of 7.75% and revenue growth of 4.6% per year, just edging out the broader Japanese market’s 4.4% revenue forecast. Mixed signals in the data, with solid long-term performance but a slight squeeze on margins, have caught...

Chugai Pharmaceutical (TSE:4519) posted earnings growth of 2.6% in the last year and has grown at an average rate of 10.7% annually over the past five years. Its net profit margin eased slightly to 32.7% from last year’s 33.9%, while analysts expect revenue and earnings to keep moving ahead of local industry averages. As investors consider the company’s robust margins and projected above-market growth, recent moderation in growth rates and share price trends may play a key role in shaping...

Canon Marketing Japan (TSE:8060) reported revenue growth of 1.1% per year, trailing the broader Japanese market’s pace of 4.4%. Earnings are projected to grow at 4.7% annually, behind the national market’s expected 8%, with the company’s net profit margin steady at 5.9% compared to last year. Investors will note that while recent profit growth is positive at 5.3% compared to the five-year average of 10.2%, the latest figures point to more modest expansion ahead rather than a dramatic shift in...

ES-CON JAPAN (TSE:8892) posted a net profit margin of 9.8%, slightly topping last year's 9.2%. EPS growth came in at 20.4% for the period, well ahead of the company’s own five-year CAGR of 17%. With five years of steady 17% annual earnings growth and a new high-quality result in hand, investors have plenty to consider regarding what is driving this momentum. See our full analysis for ES-CON JAPAN. Next, we will look at how these headline numbers compare with the main narratives shaping...